

Physiomics, which makes computer models that simulate biological cell behaviour, has agreed to collaborate over development of a prostate cancer drug....


Shares are holding onto their gains today amid much calmer trading than the volatility seen last week. In company news, international recruitment fir...


Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method...


Penny stock Physiomics fell sharply Wednesday, giving back some of last week's heavy gains, after announcing a share issue at a discount to the prevai...


The Oxford based systems biology company Physiomics said positive results have been generated in a pre-clinical study into breast cancer based on the ...


Shares in Sareum were soaring after the cancer drug discovery business announced positive results from a study into colon cancer. The study, which w...


Weakness in the US sent shares into the red and a slight rally in late trading failed to lift the FTSE 100 into positive territory. US retail sales w...


Shares in Amphion Innovations jumped after the medical and technology sector said it was cautious but confident in the strength of its model following...